###begin article-title 0
###xml 94 95 94 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN1">*</xref>
###xml 95 95 95 95 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 95 95 95 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
###xml 95 95 95 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN2"><sup><inline-graphic xlink:href="sbox.jpg"/></sup></xref>
###xml 95 102 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#9830;</sup>
The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology*diamond
###end article-title 0
###begin p 1
An incumbent of the national Ph.D. Eshkol Fellowship.
###end p 1
###begin p 2
###xml 764 769 <span type="species:ncbi:9606">human</span>
The K variant of butyrylcholinesterase (BChE-K, 20% incidence) is a long debated risk factor for Alzheimer disease (AD). The A539T substitution in BChE-K is located at the C terminus, which is essential both for BChE tetramerization and for its capacity to attenuate beta-amyloid (Abeta) fibril formation. Here, we report that BChE-K is inherently unstable as compared with the "usual" BChE (BChE-U), resulting in reduced hydrolytic activity and predicting prolonged acetylcholine maintenance and protection from AD. A synthetic peptide derived from the C terminus of BChE-K (BSP-K), which displayed impaired intermolecular interactions, was less potent in suppressing Abeta oligomerization than its BSP-U counterpart. Correspondingly, highly purified recombinant human rBChE-U monomers suppressed beta-amyloid fibril formation less effectively than dimers, which also protected cultured neuroblastoma cells from Abeta neurotoxicity. Dual activity structurally derived changes due to the A539T substitution can thus account for both neuroprotective characteristics caused by sustained acetylcholine levels and elevated AD risk due to inefficient interference with amyloidogenic processes.
###end p 2
###begin p 3
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 29 30 29 30 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fn" rid="FN5"><sup>3</sup></xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 301 302 301 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 302 302 302 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3"/>
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 364 365 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 367 368 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 515 516 503 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 654 655 636 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 790 791 772 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 812 814 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 825 827 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 849 851 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 879 881 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1085 1087 1061 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 1231 1233 1204 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 718 726 <span type="species:ncbi:9606">patients</span>
Butyrylcholinesterase (BChE),3 the secondary acetylcholine (ACh)-hydrolyzing enzyme, is associated with the neurofibrillary tangles and amyloid plaques characteristic of Alzheimer disease (AD) (1), which suggests that it functions as a potential AD modulator. BChE activity increases in the AD brain (2-4), where it co-localizes with beta-amyloid (Abeta) fibrils (5, 6). Abeta is a 39-42-amino-acid amphiphilic peptide, derived from the transmembrane domain and extracellular region of the Abeta precursor protein (7). At high concentrations, Abeta acquires a beta-sheet structure, becomes insoluble, and accumulates in neurotoxic oligomers and fibrils (8) to become the main constituent of plaques in the brain of AD patients. Recent hypotheses attribute causal roles in AD to presenilin (9), oxidative stress (10), metals (11), double hit origin (12), or mitochondrial damage (13). The alternative theories state that Abeta represents a bystander or even a protector rather than the causative factor of disease and that Abeta amyloidogenesis is secondary to other pathogenic events (14). Nevertheless, a wealth of evidence demonstrates a pivotal role for Abeta in the pathogenesis of AD, yielding the amyloid cascade hypothesis (15). According to this hypothesis, the pathological accumulation of Abeta in the brain leads to oxidative stress, neuronal destruction, and finally, the clinical syndrome of AD. It is within this context that we have studied the interactions of the Kalow variant (BChE-K) with Abeta.
###end p 3
###begin p 4
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
The C terminus of BChE functions as a tetramerization domain (16, 17) and is responsible for its quaternary organization. Four BChE monomers are held together by the aromatic interactions of seven highly conserved aromatic residues, termed the tryptophan amphiphilic tetramerization domain (WAT) (16, 17). The WAT domain interacts with proline-rich attachment domains, either via proline-rich membrane anchor in brain neurons (18) or, in neuromuscular junctions, with cholinesterase-associated collagen Q (19). In the serum, BChE tetramerization is supported by an analogous 17-mer proline-rich peptide derived from lamellipodin (20).
###end p 4
###begin p 5
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Analyzing the quaternary organization of cholinesterases is a complicated task. To date, all biologically relevant crystal structures of cholinesterases have been truncated forms that lack the C terminus of the protein (21), apart from a more recent study of full-length BChE that yielded crystal packing, which did not allow C-terminal interactions among subunits and lacked electron densities in the C terminus region, indicating structural disorder Protein Data Bank (PDB) code  (22). Of note, the crystal structure of the homologous C terminus of tetrameric synaptic acetylcholinesterase (AChE-S) could only be determined based on synthetic peptides derived from the sequence of the AChE-S tail and stabilized with a proline-rich attachment domain (23).
###end p 5
###begin p 6
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
In addition to the "usual" (BChE-U) form, BChE has nearly 40 genomic variants. The most common is BChE-K, with allelic frequencies of 0.13-0.21. BChE-K includes a single nucleotide polymorphism at position 1699 (single nucleotide polymorphism data base (dbSNP) ID: rs1803274; alleles, A/G). This leads to an alanine-to-threonine substitution at position 539, 36 residues upstream to the C terminus of BChE (24), within the tetramerization domain that we previously found to attenuate amyloid fibril formation (25).
###end p 6
###begin p 7
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1017 1025 1017 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 386 391 <span type="species:ncbi:9606">human</span>
Ample evidence supports the importance of alanine-to-threonine substitutions and their relevance to amyloidogenic processes, protein stability, and quaternary organization (). Point mutations at the dimer interface of light chain immunoglobulins decrease their stability so that the A34T polymorphism in this protein leads to systemic amyloidosis (26). An A25T mutant of the tetrameric human protein Transthyretin (TTR), associated with central nervous system amyloidosis, is prone to aggregation and exhibits drastically reduced tertiary and quaternary structural stabilities (27). The thermodynamic stability profile of the A25T TTR mutant shows that both monomers and tetramers of this variant are highly destabilized. In addition, A25T TTR tetramers dissociate very rapidly (about 1200-fold faster than the dissociation of wild-type TTR), reflecting a high degree of kinetic destabilization of their quaternary structure. These factors together probably contribute to the high propensity of A25T TTR to aggregate in vitro.
###end p 7
###begin p 8
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 739 743 739 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1091 1093 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
The capacity of serum BChE-K to hydrolyze butyrylthiocholine was reported to be reduced by 30% relative to BChE-U, for yet unclear reasons (24). The reduced hydrolytic activity of BChE-K predicts that BChE-K carriers would potentially sustain improved cholinergic transmission as compared with BChE-U carriers and has been shown to correlate with preserved performance of attention and reduced rates of cognitive decline (28). However, BChE-K carriers are refractory to cholinesterase inhibitor therapy, the current leading treatment of AD (29). This raised the question whether BChE-K functions as an AD risk or protection factor. Genotype studies are controversial, with some showing increased risk of AD for homozygote BChE-K carriers (e.g. Ref. 30), whereas others suggest a protective effect (e.g. Ref. 31). A recent meta-analysis concluded that on average, BChE-K is neither a risk factor nor a protection factor for AD (32). Based on our previous findings of the arrest of Abeta fibril formation by BChE and considering the accumulation of monomeric BChE in the most severe AD cases (33), we used a variety of chemical techniques to study the effect of the A539T substitution on BChE stability and tetramerization on the one hand and on its potency in attenuating Abeta oligomerization and fibril formation on the other.
###end p 8
###begin title 9
EXPERIMENTAL PROCEDURES
###end title 9
###begin title 10

###end title 10
###begin title 11

###end title 11
###begin title 12
Subjects
###end title 12
###begin p 13
###xml 248 250 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 108 115 <span type="species:ncbi:9606">patient</span>
###xml 363 375 <span type="species:ncbi:9606">participants</span>
321 (184 males, 137 female) healthy individuals (mean +/- S.D. age: 65.99 +/- 11.11 years) from various out-patient clinics of the Tel-Aviv Sourasky Medical Center were enrolled during the period from February 2001 to September 2004, as described (34). Written informed consent, approved by the local ethics committee (consent form 00-116), was obtained from all participants.
###end p 13
###begin title 14
Gene Polymorphism Analysis
###end title 14
###begin p 15
###xml 604 606 604 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
Genomic DNA was extracted from nucleated blood cells. For single nucleotide polymorphism analysis, a 214-bp PCR product was amplified using the forward primer 5'-CTGTACTGTGTAGTTAGAGAAAATGGC-3' (nucleotide -105 to -79 upstream to the intron 3/exon 4 boundary) and the reverse primer 5'-CTTTCTTTCTTGCTAGTGTAATCG-3' (nucleotides 1709-1686). A fluorescein-labeled anchor probe (5'-CCAGCGATGGAATCCTGCTTTCC-3'-FLU (fluorescein), nucleotides 1628-50) and a one base apart LC-Red-640-labeled detection probe (5'-CTCCCATTCTGCTTCATCAATATT-3'-PHO (phosphate), nucleotides 1603-26) were used as reported previously (35).
###end p 15
###begin title 16
Serum Cholinesterase Analysis
###end title 16
###begin p 17
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 490 491 490 491 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 655 656 643 644 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 678 679 666 667 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 708 709 696 697 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 731 732 719 720 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 732 733 720 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 769 770 757 758 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 818 820 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 158 163 <span type="species:ncbi:42554">tetra</span>
Acetylthiocholine (ATCh) hydrolytic activities were assessed in a microtiter plate assay as described, with or without the selective BChE inhibitor iso-OMPA (tetra(monoisopropyl)pyrophosphorotetramide) (36). Calculated BChE ATCh hydrolytic activity was defined as the total serum ability to hydrolyze ATCh after subtraction of AChE hydrolytic activity. For stability tests, serum-derived samples of genotyped KK, UK, and UU carriers, diluted 1:10 in saline, were incubated overnight in 0-2 m urea at 37 degreesC and electrophoretically separated (2 h, 4 degreesC) in 6% non-denaturing polyacrylamide gels. This was followed by activity staining with 3.0 mm copper sulfate, 0.5 mm potassium ferricyanide, 10 mm sodium citrate, 1.6 mmS-butyrylthiocholine iodide, and 65 mm phosphate buffer, pH 6.0, at room temperature (37).
###end p 17
###begin title 18
Statistical Analysis
###end title 18
###begin p 19
###xml 256 257 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 264 265 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Continuous data were summarized and displayed as mean +/- S.D. Distributions of calculated BChE activities were assessed by the Kolmogorov-Smirnov Normality test. The difference between genotypes of mean calculated activities was evaluated using Student's t test; p < 0.05 was considered statistically significant. SPSS for Windows (version 15.0, SPSS Inc.) software was used to carry out all statistical analyses.
###end p 19
###begin title 20
Peptides
###end title 20
###begin p 21
###xml 25 29 22 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;40</sub>
###xml 218 219 215 216 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 345 347 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 117 122 <span type="species:ncbi:9606">human</span>
Peptides used were: Abeta1-40, (Sigma, Jerusalem, Israel), BSP-U and BSP-K, derived from the C-terminal sequences of human BChE (EC 3.1.1.8.) variants (U, GNIDEAEWEWKAGFHRWNNYMMDWKNQFNDYT; K, A6T), and the 17-mer poly-l-proline (PolyP) sequence (PPPPPPPPPPPPPPPLP), derived from lamellipodin, which promotes the assembly of BChE into tetramers (20) (GenScript Corp., Piscataway, NJ). All peptides were purified to >90%, as validated by mass spectrometry analyses.
###end p 21
###begin title 22
Surface Plasmon Resonance
###end title 22
###begin p 23
###xml 11 13 11 13 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
The ProteOnTM XPR36 protein interaction array system (Bio-Rad, Haifa, Israel) was used to study the interaction of a recombinant full-length BChE (rBChE-U) and the peptides BSP-U and BSP-K, with a polyclonal antibody raised against rBChE-U (38). The protein and peptides were immobilized on GLC chips (Bio-Rad) using standard amine coupling. Arbitrary units (resonance unit) values of binding to the chip were 6000, 900, and 600, respectively. The antibody, as analyte, was diluted serially in phosphate-buffered saline containing 0.005% Tween 20 and injected at five concentrations (3.12-50 mug/ml). All interactions were carried out at 25 degreesC. Immobilized IgG was used as a reference for background subtraction.
###end p 23
###begin title 24
NMR-derived Solution Analysis of BSP Peptides
###end title 24
###begin p 25
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d<sub>6</sub></italic>
###xml 103 104 103 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 712 714 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 761 763 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
Peptides were dissolved in 60% d6-DMSO (Aldrich) in double distilled water with 0.03 weight percent NaN3 and measured at 29 degreesC. BSP samples were measured alone and with PolyP at a 4:1 molar ratio (verified by relative peak-ratios in NMR spectra). The pH was titrated to 5.10 +/- 0.05 for all samples. NMR experiments were performed on a Bruker Avance 600 MHz DMX spectrometer operating at the proton frequency of 600.13 MHz, using a 5-mm selective probe equipped with a self-shielded xyz-gradient coil. The transmitter frequency was set on the hydrogen-deuterium exchange in water signal, which was calibrated at 4.735 ppm. total correlation spectroscopy, using the MLEV-17 pulse scheme for the spin lock (39), and nuclear Overhauser effect spectroscopy (40) experiments were acquired under identical conditions for all samples, using gradients for water saturation. The nuclear Overhauser effect spectroscopy experiments were acquired with a mixing time of 200 ms.
###end p 25
###begin p 26
###xml 112 113 112 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="other" rid="FN6"><sup>4</sup></xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
Spectra were processed and analyzed with the XWINNMR (Bruker Analytische Messtechnik GmbH) and SPARKY3 software.4 Zero filling in the F1 dimension and data apodization with a shifted squared sine bell window function in both dimensions were applied prior to Fourier transformation. The baseline was further corrected in the F2 dimension with a quadratic polynomial function. Resonance assignment followed the sequential assignment methodology developed by Wuthrich (41).
###end p 26
###begin title 27
Abeta Oligomerization
###end title 27
###begin p 28
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 306 307 299 300 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 361 362 350 351 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
###xml 554 556 543 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 672 674 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 676 678 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
Oxidative photo-induced cross-linking of unmodified proteins (42) was used to study the effect of BSP peptides on Abeta oligomerization. Abeta was preincubated in hexafluoroisopropanol (Acros Organics, Geel, Belgium), lyophilized and redissolved in double distilled water to a final concentration of 100 mum. Abeta was incubated alone or in the presence of 1 mum protein or peptides over 24 h at room temperature. Aliquots were removed at 0, 4, 7, 8, and 22 h and centrifuged (30 min, 14,000 rpm). Soluble fractions were treated as described previously (43). Thioflavine T and bis-ANS fluorescence measurements and transmission electron microscopy were done as described (25, 43).
###end p 28
###begin title 29
Circular Dichroism Measurements
###end title 29
###begin p 30
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
Direct CD spectra were recorded using a CD Jasco J-810 spectropolarimeter (Easton, MD) in 1-mm path length quartz cuvettes, Hellma 100-QS (Hellma GmbH & Co. KG, Mulheim/Baden, Germany). Recordings were at 0.1-nm intervals in a spectral range of 185-260 nm. The CD spectra were computationally deconvoluted, using the K2D analysis program (44). The concentration of BSP peptides was below the level of detection so that the spectra measured changes in Abeta only.
###end p 30
###begin title 31
Cell Culture
###end title 31
###begin p 32
###xml 325 326 325 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 625 627 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 643 645 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 199 205 <span type="species:ncbi:9913">bovine</span>
Human neuroblastoma SH-SY5Y cells (ATCC, Manassas, VA) were grown in a 1:1 mixture of minimal essential medium (Sigma-Aldrich, Rehovot, Israel) and Ham's modified medium F-12 (Sigma), with 10% fetal bovine serum (Biological Industries, Beit-Haemek, Israel). Cells were plated in 24-well plates (Nunc, Roskilde, Denmark) at 105 cells/well in 500 mul of medium and allowed to attach overnight. Abeta was preincubated for 4 h, diluted 1:10 (final volume 500 mul) with phenol red-free RPMI 1640 (Sigma) containing 10% serum, and added to the cells. Cell viability was determined using lactate dehydrogenase (LDH) release assays (45) as described (38).
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34

###end title 34
###begin title 35

###end title 35
###begin title 36
BChE-K Shows Reduced Stability and Hydrolytic Activity
###end title 36
###begin p 37
###xml 19 25 19 25 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 27 28 27 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 33 34 33 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 475 476 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 487 493 481 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 493 494 487 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
The BChE genotype (Fig. 1, A and B) was determined using nucleated blood cell DNA from apparently healthy volunteers who also donated serum for hydrolytic activity measurements. The observed genotype distribution included 72.0% UU, 23.2% UK, and 4.4% KK variants, consistent with the Hardy-Weinberg equilibrium. The corresponding mean calculated ATCh hydrolytic activities of serum BChE from these subjects were 1103.31 +/- 219.34, 1031.16 +/- 198.56, and 949.05 +/- 203.47 (p = 0.011) (Fig. 1C). The decline in ATCh hydrolytic activity from heterozygous to homozygous carriers indicated gene dose dependence.
###end p 37
###begin p 38
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BChE</italic>
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The <italic>BChE</italic> gene and its usual U and K variant protein products.</bold>
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 305 306 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
The BChE gene and its usual U and K variant protein products.A, BChE location on chromosome 3q26.1-q26.2 and its gene structure (56). B, the C-terminal DNA and amino acid sequences of BChE-U and -K. The predicted secondary structure of the amino acid substitution (enlarged) is shown above the sequences. C, histograms of measured BChE activity in apparently healthy carriers of the UU, UK, and KK genotypes. Units are nmol of acetylthiocholine hydrolyzed/min/ml serum.
###end p 38
###begin p 39
###xml 420 426 420 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 587 588 587 588 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</sc>
The location of the A539T substitution in the C terminus, which is distant from the hydrolytic site of the enzyme, suggested that its impaired stability caused the reduced activity. To challenge this prediction, the inherent stability of BChE-U and BChE-K was compared by incubating serum samples from genotyped subjects in increasing concentrations of urea followed by native gel electrophoresis and activity staining (Fig. 2A). Both BChE-U and BChE-K are enzymatically active tetramers; however, the enzymatic activity of BChE-K tetramers was greatly reduced following incubation in 1 m urea, unlike BChE-U, which was resistant to this treatment. This suggested that the hydrolytic activity was rapidly lost once BChE-K tetramers disassemble.
###end p 39
###begin p 40
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BChE and derived peptides differ in stability and antibody recognition.</bold>
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 222 223 222 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 547 548 547 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 553 554 553 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 713 715 713 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RU</italic>
###xml 810 812 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ab</italic>
BChE and derived peptides differ in stability and antibody recognition.A, native gel subjected to activity staining of homozygous BChE-U and -K serum samples following incubation in the noted molar concentrations of urea. B, surface plasmon resonance analyses. Polyclonal anti-rBChE-U antibodies in the noted concentrations were injected against immobilized rBChE-U, BSP-U, and BSP-K. Signals are dose-dependent. Note the 10-fold resonance unit scale difference between rBChE-U and BSP-U signals and the lack of detectable interaction with BSP-K. C and D, positive surface plasmon resonance response of BSP-U but neither BSP-K nor IgG. Note the exceedingly low response scale despite adding 6000 resonance units (RU) of IgG, attesting to the specificity of the observed response with the anti-BChE antibodies (Ab).
###end p 40
###begin title 41
BSP Peptides Show NMR Spectral Differences
###end title 41
###begin p 42
###xml 235 237 235 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 412 418 412 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 420 421 420 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 501 507 501 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 634 638 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 995 997 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 187 193 <span type="species:ncbi:9986">rabbit</span>
We investigated the structural origin for the instability of BChE-K by analyzing the corresponding 32-residue synthetic peptides, BSP-K and BSP-U, for their interaction with a polyclonal rabbit antibody elicited toward intact rBChE-U (46). Surface plasmon resonance analysis demonstrated a dose-dependent interaction of anti-rBChE-U antibodies with rBChE-U and BSP-U (albeit less profoundly) but not with BSP-K (Fig. 2, B and C). Immunoglobulin G, which does not bind to the antibody against rBChE-U (Fig. 2D) served as an immobilized control employed as a subtractable "baseline" in all cases. Additionally, other injected proteins (e.g. RACK1) did not bind rBChE or the two peptides (data not shown).These results supported the concept of structural differences between these two peptides and suggested that distinct tetramerization capacities are involved. Interactions of BSP peptides were studied by incubating them with the synthetic PolyP peptide, which facilitates BChE tetramerization (20). NMR was used to follow both BSP peptides interactions with PolyP by tracking chemical shift deviations in the amide-aliphatic interactions (fingerprint region). Because PolyP fortunately has no amide protons (apart from one leucine), it does not appear in the fingerprint region of the BSP spectra.
###end p 42
###begin p 43
###xml 300 301 300 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 387 393 387 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 427 433 427 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
The spectrum of BSP-U was assigned based on total correlation spectroscopy and nuclear Overhauser effect spectroscopy spectra acquired under identical conditions and was the basis for assignments of both BSP peptides with 4:1 ratios of peptide to PolyP (see : , BSP-U; , BSP-U+PolyP; , BSP-K; , BSP-K+PolyP). Deviations of amide chemical shifts of each peptide in interaction with PolyP versus the free state are summarized in Fig. 3.
###end p 43
###begin p 44
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PolyP-induced NMR chemical shift deviations.</bold>
###xml 158 172 158 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">central thread</italic>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pink</italic>
###xml 403 407 403 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue</italic>
PolyP-induced NMR chemical shift deviations. NMR-measured chemical shift differences between spectra of BSP-U and -K bound and non-bound to PolyP (shown as a central thread in the structure) are displayed. Right, location of residues that showed significant chemical shifts on the BSP structure (built according to PDB structure ) are colored in pink. Residues near the kink of the helix at Gly-546 (in blue) were significantly shifted in both BSP peptides.
###end p 44
###begin p 45
Upon adding PolyP, BSP-U showed mainly upfield chemical shift deviations, suggesting that the amide protons are more shielded in this variant when interacting with PolyP. The amide protons of BSP-K showed the opposite, except for residues His-15 and Arg-16, which were shielded, and Asn-2, Trp-24, and Tyr-31, which were deshielded in both peptides. The distinct interactions observed for these peptides with PolyP suggested inherent differences between their tetramerization potency, compatible with the reduced stability of BChE-K as compared with BChE-U.
###end p 45
###begin title 46
rBChE-U Monomers Suppress Fibril Formation Less Effectively than Recombinant Dimers or Native BChE Tetramers
###end title 46
###begin p 47
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 443 445 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 448 454 436 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 454 455 442 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 828 834 813 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 834 835 819 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 997 1003 979 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1003 1004 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1009 1014 991 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">inset</italic>
###xml 1110 1116 1092 1098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1116 1117 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 1167 1173 1149 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1173 1174 1155 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 1475 1481 1454 1460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 1481 1482 1460 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 329 334 <span type="species:ncbi:9925">goats</span>
###xml 1154 1159 <span type="species:ncbi:9606">human</span>
The C-terminal domains of both BChE dimers and monomers are relatively exposed to the surrounding environment, as modeled based on the tetrameric structure of AChE-S (Fig. 4A). Separate fractions of BChE dimers and monomers were used to compare the effects caused by these C termini. rBChE-U production in the milk of transgenic goats yielded primarily dimeric protein, with approximately10% monomeric fraction, as shown by mass spectrometry (46) (Fig. 4B). Column chromatography was used to separate monomers from dimers. ThT fluorescence measurements showed that isolated fractions of highly purified rBChE-U monomers and dimers both attenuated fibril formation at a molar ratio of 1:100 to Abeta. However, monomeric and dimeric rBChE-U showed different durations of the lag and growth phases in the fibril formation process (Fig. 4C). Dimeric rBChE-U attenuated Abeta fibril formation more than the monomeric BChE and presented a longer lag time and 20% less fluorescent signal at the plateau (Fig. 4C and inset). Furthermore, calculating the rate of fibril formation revealed that recombinant BChE dimers (Fig. 4D), and yet more so, native BChE from human serum (Fig. 4E) attenuate this process, suggesting direct association of this rate with the number of enzyme subunits. Inversely, a bis-ANS response curve to rBChE interaction with Abeta showed an apparently similar time scale and sustained fluorescence signal, unlike the reduced signal in the thioflavin T tests (Fig. 4F), both supporting our working hypothesis.
###end p 47
###begin p 48
###xml 0 79 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rBChE-U dimers attenuate A&#946; fibril formation more effectively than monomers.</bold>
###xml 79 80 76 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 140 141 137 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 251 253 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">AU</italic>
###xml 272 273 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 420 425 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inset</italic>
###xml 497 498 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 512 513 503 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 516 517 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 522 523 513 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 668 669 659 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</italic>
###xml 699 700 690 691 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 703 704 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 636 641 <span type="species:ncbi:9606">human</span>
rBChE-U dimers attenuate Abeta fibril formation more effectively than monomers.A, initial dimer and monomer content in rBChE-U preparation. B, modeled BChE-U monomers and dimers built according to PDB structure  of the tetrameric structure of AChE-S. AU, arbitrary units. C, ThT fluorescence demonstrating that highly purified dimers of rBChE-U suppressed Abeta fibril formation more efficiently than monomeric rBChE-U. Inset, percentage of attenuated Abeta fibril formation elicited by monomers (m) and dimers (d). D and E, rates of fluorescence changes demonstrating the difference in the capacity for attenuating fibril formation by human recombinant rBChE dimers (d) or serum-derived tetramers (t). F, bis-ANS kinetics demonstrating an apparently similar time scale and sustained fluorescence signal in the presence of bis-ANS as compared with the suppressed signal with ThT, both supporting our working hypothesis.
###end p 48
###begin p 49
###xml 547 553 526 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
The distinct structural features of BSP-K could potentially impair its ability to modulate Abeta conversion to beta-sheet conformation. This was assessed by incubating Abeta alone or with BSP peptides and following the CD spectrum for 24 h. Deconvoluted spectra of Abeta samples incubated alone showed a gradual increase in the content of beta-sheets, from 26 to 50% within 2.5 h. In contrast, adding rBChE-U or BSP peptides to Abeta accelerated the increase in beta-sheet content, which reached an apparent plateau within seconds (50 s, to 48%) (Fig. 5).
###end p 49
###begin p 50
###xml 0 71 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CD evidence for BChE-accelerated conversion to &#946;-sheet conformation.</bold>
###xml 148 158 142 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">upper plot</italic>
###xml 199 209 193 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lower plot</italic>
CD evidence for BChE-accelerated conversion to beta-sheet conformation. CD deconvoluted spectra demonstrate a rapid increase in beta-sheet content (upper plot) and rapid decrease in helical content (lower plot) with the addition of rBChE-U, BSP-U, and BSP-K, as compared with the increase in beta-sheet content seen with Abeta alone.
###end p 50
###begin title 51
BSP-K Attenuates Abeta Oligomerization Less Effectively than BSP-U
###end title 51
###begin p 52
###xml 171 177 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
Further studies of Abeta oligomerization involved cross-linking of Abeta in the presence or absence of BSP-U or BSP-K and separation of the soluble fractions by SDS-PAGE (Fig. 6). Abeta alone precipitated rapidly, within 4 h. Both BSP peptides prolonged the time Abeta oligomers remained in solution, but BSP-U prolonged the persistence of amyloid oligomers in solution more effectively than BSP-K; after 8 h of incubation, no oligomeric forms of Abeta remained in the soluble phase in the presence of BSP-K, whereas in the presence of BSP-U, they lasted nearly 22 h. This supports the view that BSP-K is less capable of interacting both with PolyP and with Abeta than BSP-U.
###end p 52
###begin p 53
###xml 0 72 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BSP-K sustains less cross-linked A&#946; oligomers in solution than BSP-U.</bold>
###xml 72 73 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 166 168 160 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MW</italic>
###xml 196 201 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">no CL</italic>
###xml 221 222 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 252 256 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Prot</italic>
###xml 267 268 261 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
BSP-K sustains less cross-linked Abeta oligomers in solution than BSP-U.A, 16% Tris-Tricine gel demonstrating BSP peptide interference with oligomerization of Abeta. MW, molecular weight markers; no CL, no cross-linking. B, the cross-linking reaction. Prot, protein. C, quantification of Abeta dimers and trimers in solution, in the presence of BSP-K and BSP-U.
###end p 53
###begin title 54
rBChE-U Attenuates Abeta Fibril Formation and Induces Fibril Disassembly
###end title 54
###begin p 55
###xml 588 594 576 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 594 595 582 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
Transmission electron microscopy (TEM) was used to quantify longer and more developed Abeta fibrils, formed in the presence or absence of rBChE-U and BSP peptides. Following 48 h of incubation, Abeta alone formed mostly 50-60-nm-long fibrils, with some fibrils reaching up to 300 nm. In the presence of either of the BSP peptides, however, the majority of Abeta fibrils were 20-30-nm long with none longer than 120 nm. In the presence of rBChE-U, a dramatic reduction in the formation of fibrils of all length groups was seen, as compared with Abeta incubated alone or with BSP peptides (Fig. 7A).
###end p 55
###begin p 56
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">rBChE-U attenuates fibril formation more than BSP peptides and induces fibril disassembly.</bold>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 209 210 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 450 451 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 456 457 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 536 542 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 589 595 580 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 663 664 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 822 824 810 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FU</italic>
rBChE-U attenuates fibril formation more than BSP peptides and induces fibril disassembly.A, computer-processed TEM photomicrographs following 24-h incubations of Abeta alone or with BSP-U, BSP-K, or rBChE-U. B, fibrils were clustered into groups according to their length. Note that both BSP peptides shifted the Abeta fibrils from relatively long to numerous short fibrils, whereas rBChE-U suppressed the formation of fibrils of all length groups. C and D, Abeta alone or with rBChE-U added after different incubation times (shown by arrows). Plots present the fibril number or branches versus fibril length. Note the apparent disassembly of preformed fibrils. E, ThT fluorescence curves for the BSP-U and the BSP-K peptides. Note that BSP-U, but not BSP-K, was capable of repressing the ThT increment induced by Abeta. FU, fluorescence units.
###end p 56
###begin p 57
###xml 436 442 433 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 444 447 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;D</italic>
###xml 675 681 672 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 681 682 678 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
Kinetics of TEM showed a pronounced decrease over time both in the number and in the degree of branching of the fibrils in the presence of the peptides relative to incubation of Abeta alone. Adding rBChE-U at any time after initiation substantially further reduced the number of fibrils in a manner dependent on the duration of rBChE-U incubation for all fibril length fractions. Also, adding rBChE-U decreased the extent of branching. Fig. 7, A-D, present these analyses and the corresponding quantifications, demonstrating active disassembly of fibrils by rBChE-U. Of note, ThT fluorescence measurements showed suppressed increment in the presence of BSP-U, but not BSP-K (Fig. 7E), demonstrating a principal difference between these two peptides.
###end p 57
###begin title 58
BSP Peptides Are Poor Neuroprotectors as Compared with rBChE-U
###end title 58
###begin p 59
###xml 77 79 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 81 83 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 199 204 <span type="species:ncbi:9606">human</span>
Cytotoxicity of Abeta has been attributed to low molecular weight oligomers (47, 48). Therefore, Abeta cytotoxicity and the cytoprotection provided by BSP peptides and rBChE-U was tested on cultured human neuroblastoma SH-SY5Y cells. The cells were incubated alone, in the presence of Abeta and in the presence of Abeta with BSP peptides or rBChE-U. After 72 h, an LDH release assay for cell viability showed a 26% increase in LDH release from Abeta-treated cells as compared with controls. rBChE-U prevented 85 +/- 8% of this Abeta-induced LDH increase, indicating that it protects the cells from the Abeta-dependent toxicity. The BSP peptides yielded only small, variable (10-17%) changes in LDH release, suggesting that they can only function to attenuate Abeta fibril formation as an integral part of the intact BChE protein.
###end p 59
###begin title 60
DISCUSSION
###end title 60
###begin p 61
Various chemical and biological approaches were combined to explore the role of the BChE-K variant in Abeta accumulation, which characterizes AD pathophysiology. Our findings attribute many of the features observed for BChE-K carriers in AD to structural origins. We found BChE-K to be inherently unstable as compared with BChE-U, which may induce elevated ACh levels in its carriers, thereby delaying AD onset. However, BChE-K was considerably less effective in attenuating the accumulation of Abeta fibrils than BChE-U. Although bearing in mind the alternative hypotheses for the role played by Abeta in AD, our findings suggest that BChE-K may pose either a risk or a protective factor in AD, in a context-dependent manner affected by other variables. It is conceivable that distinct population studies reflect these variables so that the null differences observed in the meta-analysis are less meaningful than the different population studies. Our findings attribute the association between BChE-K and AD progression to a structural origin, with dual activity: impaired stability and quaternary organization of BChE-K as compared with BChE-U and the consequently suppressed hydrolytic activity, counterbalanced by aberrant interactions with Abeta. This statement is supported by several considerations, as listed below.
###end p 61
###begin p 62
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 516 518 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
The genetic implications of BChE-K in AD progression were studied comprehensively (), but the location of the A539T polymorphism within the tetramerization domain of BChE (16, 17) has not been considered. Our current findings suggest that the BChE-K C-terminal substitution impairs both its stability and its intersubunit interactions. This is supported by findings where tetrameric serum BChE is thermostable, demonstrating that monomeric BChE loses hydrolytic activity within 10 min when incubated at 48 degreesC (49).
###end p 62
###begin p 63
###xml 499 503 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 509 511 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 906 908 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1711 1713 1678 1680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
NMR detected chemical shift differences between BSP peptides upon adding PolyP. Nine residues in three regions of BSP-U showed chemical shift deviations (Deltadelta >/= 0.02), as compared with only two BSP-K residues. Also, the changes observed in the BSP-U spectra upon binding PolyP were larger than those in the BSP-K spectra, indicating that PolyP induces greater organization in BSP-U. Changes in NMR chemical shift largely indicate those residues that undergo structural changes upon binding (e.g. Ref. 50). The distribution of BSP regions whose adjacent chemical environment changed, including the middle region and both termini, may indicate a change in the relative tilt of the helices or a motion in the hinge of the helix (at Gly-546/Gly-13) due to rearrangement of the kink. Such motion may result from local helix disruption due to the A539T mutation; according to the Chou-Fasman parameters (51), alanine is one of the strongest helix stabilizers (helix propensity: 1.42), whereas threonine is one of the strongest beta-sheet formers (beta-sheet propensity: 1.19). One possible explanation of our findings is that threonine may slightly disrupt the helix or the amphiphilic distribution. The preference of threonine to form beta-sheets is crucial in the context of amyloidogenic processes as all amyloid fibrils share a common cross-beta-sheet structure. Another example of a disrupted helix originating from an alanine-to-threonine substitution is the solid-state NMR study that showed that the familial Parkinson disease-associated mutation A53T, which occurs in the N terminus of the amphiphilic helical alpha-synuclein, is more prone to forming beta-structures than wild-type alpha-synuclein (52).
###end p 63
###begin p 64
###xml 353 355 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
In BChE-K, the disrupted helix would likely be further destabilized by hydrogen bonding between Thr-539 and Glu-543, three amino acids away. Local unwinding of the helix could lead to loss of the ability of the adjacent pivotal tryptophan (Trp-541), which we previously demonstrated disrupts this amphiphilic helix, to attenuate Abeta fibril formation (25). Trp-541 contributes to structural interactions only when it is located at the polar face of an amphiphilic helix; if the helix becomes twisted or distorted, Trp-541 is no longer at the polar face, and the entire helix may cease to be amphiphilic.
###end p 64
###begin p 65
###xml 451 461 448 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">vice versa</italic>
###xml 1055 1061 1043 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Fig. 8</xref>
Various Abeta aggregation pathways may exist simultaneously, and distinct inhibitors may affect only some of these. For instance, if oligomers are essential intermediates on the pathway to fibril formation, inhibitors that block oligomer formation would ultimately block fibril formation as well. Alternatively, if fibrils and oligomers represent distinct aggregation pathways, some inhibitors might block oligomerization but not fibril formation and vice versa. We followed Abeta oligomerization by cross-linking, and we followed fibril formation by TEM. In both approaches, rBChE-U and BSP peptides attenuated both oligomer and fibril formation, albeit with different efficiencies. This tentatively implies that under the experimental conditions employed, oligomers are fibril intermediates. One possible explanation of the observed attenuation effects is that both rBChE-U and the BSP peptides can induce a shift of Abeta accumulation toward a stabilized Abeta oligomer, as large as 100-mer, if judged by the 1:100 molar ratio of effective inhibition (Fig. 8).
###end p 65
###begin p 66
###xml 0 55 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BChE-induced changes in the A&#946; accumulation process.</bold>
BChE-induced changes in the Abeta accumulation process. The Abeta aggregation pathway involves a set of mutually dependent reactions in complex equilibria (monomer left arrow over right arrow dimer left arrow over right arrow oligomer left arrow over right arrow fibril). The transition from helical structure to beta-sheet conformation was studied by CD, oligomerization was followed by cross-linking, and fibril formation was tracked by ThT fluorescence and TEM. These reactions along the Abeta aggregation pathway are differentially affected by rBChE-U, BSP-U, and BSP-K.
###end p 66
###begin p 67
###xml 150 152 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 154 156 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 243 245 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 247 249 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 462 464 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 466 468 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
The amyloid hypothesis postulates that increased Abeta production and deposition plays a key role in triggering neuronal dysfunction and death in AD (15, 53). Many argue that the toxicity of Abeta lies in its soluble oligomeric intermediates (47, 48) rather than the insoluble fibrils that accumulate in AD plaques. Recent data indicate that small soluble oligomeric forms, as short as dimers, are the main neurotoxic species involved in the pathogenesis of AD (17, 18). Our current findings indicate that neuroprotection may be achieved by shifting the equilibria of Abeta accumulation away from the potentially more hazardous oligomeric species, such as by BChE. In cross-linking and electron microscopy experiments, BSP peptides affected Abeta assembly less efficiently than rBChE-U. Also, BSP-K displayed less effective attenuation than BSP-U, possibly because it interacted with the Abeta monomers and/or intermediates less tightly. The differences in interactions are likely to be involved in the rBChE-U protection from Abeta neurotoxicity in cultured cells, where the peptides failed to provide protection.
###end p 67
###begin p 68
###xml 146 148 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 648 650 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
The specific association between Abeta and the cell membrane has been shown to be the initial step in the chain of events that leads to toxicity (54). Our findings demonstrate that rBChE-U interacts with the neurotoxic Abeta oligomers, whereas Abeta-BSP interactions are much less effective. This is compatible with the hypothesis that BChE-U blocks the association of Abeta oligomers with the cell membrane. Therefore, BSP peptides are essential but are unable to promote such protection on their own. Furthermore, we demonstrated that the rBChE-U disruption extended to active fibril disassembly, compatible with a mechanism suggested by others (55), whereby inhibitor binding to the edge of the fibril leads to disassembly of the fibril by gradual strand removal. However, this mechanism requires high ratios of inhibitor to Abeta and therefore does not fit the 1:100 ratio we observed, in which a single rBChE-U molecule can initiate breakdown of large Abeta oligomers. Rather, our results suggest that the symmetry between the layers is broken by steric hindrance, which induces structural instabilities due to the Ala to Thr mutation and leads to collapse of the entire structure of the fibril. The same structural features that destabilize BChE-K are therefore those that make it less effective as a neuroprotector.
###end p 68
###begin title 69
Supplementary Material
###end title 69
###begin title 70
[Author Profile]
###end title 70
###begin p 71
This work was supported by a grant from the Hurwitz Fund (to H. S.).
###end p 71
###begin p 72
###xml 0 0 0 0 <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="sbox.jpg"/>
###xml 0 0 0 0 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><inline-graphic xlink:href="sbox.jpg"/></sup>
 The on-line version of this article (available at ) contains two  and four .
###end p 72
###begin p 73
 T. D. Goddard and D. G. Kueller, University of California, San Francisco, CA, personal communication.
###end p 73
###begin p 74
###xml 28 32 28 32 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G1">BChE</term>
###xml 32 53 32 53 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="75">butyrylcholinesterase</p>
###xml 32 53 32 53 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="75">butyrylcholinesterase</p></def>
###xml 28 53 28 53 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G1">BChE</term><def><p textid="75">butyrylcholinesterase</p></def></def-item>
###xml 53 59 53 59 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G2">BChE-K</term>
###xml 59 80 59 80 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="76">Kalow variant of BChE</p>
###xml 59 80 59 80 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="76">Kalow variant of BChE</p></def>
###xml 53 80 53 80 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G2">BChE-K</term><def><p textid="76">Kalow variant of BChE</p></def></def-item>
###xml 80 86 80 86 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G3">BChE-U</term>
###xml 86 96 86 96 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="77">usual BChE</p>
###xml 86 96 86 96 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="77">usual BChE</p></def>
###xml 80 96 80 96 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G3">BChE-U</term><def><p textid="77">usual BChE</p></def></def-item>
###xml 96 103 96 103 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G4">rBChE-U</term>
###xml 103 122 103 122 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="78">recombinant rBChE-U</p>
###xml 103 122 103 122 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="78">recombinant rBChE-U</p></def>
###xml 96 122 96 122 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G4">rBChE-U</term><def><p textid="78">recombinant rBChE-U</p></def></def-item>
###xml 122 125 122 125 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G5">BSP</term>
###xml 125 155 125 155 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="79">BChE-derived synthetic peptide</p>
###xml 125 155 125 155 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="79">BChE-derived synthetic peptide</p></def>
###xml 122 155 122 155 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G5">BSP</term><def><p textid="79">BChE-derived synthetic peptide</p></def></def-item>
###xml 155 158 155 158 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G6">ACh</term>
###xml 158 171 158 171 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="80">acetylcholine</p>
###xml 158 171 158 171 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="80">acetylcholine</p></def>
###xml 155 171 155 171 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G6">ACh</term><def><p textid="80">acetylcholine</p></def></def-item>
###xml 171 175 171 175 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G7">AChE</term>
###xml 175 195 175 195 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="81">acetylcholinesterase</p>
###xml 175 195 175 195 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="81">acetylcholinesterase</p></def>
###xml 171 195 171 195 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G7">AChE</term><def><p textid="81">acetylcholinesterase</p></def></def-item>
###xml 195 201 195 201 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G8">AChE-S</term>
###xml 201 214 201 214 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="82">synaptic AChE</p>
###xml 201 214 201 214 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="82">synaptic AChE</p></def>
###xml 195 214 195 214 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G8">AChE-S</term><def><p textid="82">synaptic AChE</p></def></def-item>
###xml 214 218 214 218 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G9">ATCh</term>
###xml 218 235 218 235 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="83">acetylthiocholine</p>
###xml 218 235 218 235 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="83">acetylthiocholine</p></def>
###xml 214 235 214 235 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G9">ATCh</term><def><p textid="83">acetylthiocholine</p></def></def-item>
###xml 235 237 235 237 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G10">AD</term>
###xml 237 254 237 254 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">Alzheimer disease</p>
###xml 237 254 237 254 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="84">Alzheimer disease</p></def>
###xml 235 254 235 254 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G10">AD</term><def><p textid="84">Alzheimer disease</p></def></def-item>
###xml 254 259 254 256 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G11">A&#946;</term>
###xml 259 271 256 265 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">&#946;-amyloid</p>
###xml 259 271 256 265 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">&#946;-amyloid</p></def>
###xml 254 271 254 265 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G11">A&#946;</term><def><p textid="85">&#946;-amyloid</p></def></def-item>
###xml 271 276 265 270 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G12">polyP</term>
###xml 281 282 275 276 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 276 290 270 284 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">poly-<sc>l</sc>-proline</p>
###xml 276 290 270 284 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">poly-<sc>l</sc>-proline</p></def>
###xml 271 290 265 284 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G12">polyP</term><def><p textid="86">poly-<sc>l</sc>-proline</p></def></def-item>
###xml 290 297 284 291 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G13">bis-ANS</term>
###xml 297 342 291 336 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">4,4&#8242;-dianilino-1,1&#8242;-binaphthyl-5,5&#8242;-sulfonate</p>
###xml 297 342 291 336 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">4,4&#8242;-dianilino-1,1&#8242;-binaphthyl-5,5&#8242;-sulfonate</p></def>
###xml 290 342 284 336 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G13">bis-ANS</term><def><p textid="87">4,4&#8242;-dianilino-1,1&#8242;-binaphthyl-5,5&#8242;-sulfonate</p></def></def-item>
###xml 342 345 336 339 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G14">TTR</term>
###xml 345 358 339 352 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">Transthyretin</p>
###xml 345 358 339 352 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">Transthyretin</p></def>
###xml 342 358 336 352 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G14">TTR</term><def><p textid="88">Transthyretin</p></def></def-item>
###xml 358 361 352 355 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G15">LDH</term>
###xml 361 382 355 376 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="89">lactate dehydrogenase</p>
###xml 361 382 355 376 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="89">lactate dehydrogenase</p></def>
###xml 358 382 352 376 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G15">LDH</term><def><p textid="89">lactate dehydrogenase</p></def></def-item>
###xml 382 385 376 379 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G16">TEM</term>
###xml 385 417 379 411 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">transmission electron microscopy</p>
###xml 385 417 379 411 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">transmission electron microscopy</p></def>
###xml 382 417 376 411 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G16">TEM</term><def><p textid="90">transmission electron microscopy</p></def></def-item>
###xml 417 420 411 414 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G17">ThT</term>
###xml 420 432 414 426 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="91">thioflavin T</p>
###xml 420 432 414 426 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="91">thioflavin T</p></def>
###xml 417 432 411 426 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G17">ThT</term><def><p textid="91">thioflavin T</p></def></def-item>
###xml 432 439 426 433 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G18">Tricine</term>
###xml 439 440 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 439 487 433 481 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="92"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p>
###xml 439 487 433 481 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="92"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def>
###xml 432 487 426 481 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G18">Tricine</term><def><p textid="92"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def></def-item>
###xml 487 491 481 485 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="G19">DMSO</term>
###xml 491 510 485 504 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="93">dimethyl sulfoxide.</p>
###xml 491 510 485 504 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="93">dimethyl sulfoxide.</p></def>
###xml 487 510 481 504 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term id="G19">DMSO</term><def><p textid="93">dimethyl sulfoxide.</p></def></def-item>
###xml 28 510 28 504 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><def-item><term id="G1">BChE</term><def><p textid="75">butyrylcholinesterase</p></def></def-item><def-item><term id="G2">BChE-K</term><def><p textid="76">Kalow variant of BChE</p></def></def-item><def-item><term id="G3">BChE-U</term><def><p textid="77">usual BChE</p></def></def-item><def-item><term id="G4">rBChE-U</term><def><p textid="78">recombinant rBChE-U</p></def></def-item><def-item><term id="G5">BSP</term><def><p textid="79">BChE-derived synthetic peptide</p></def></def-item><def-item><term id="G6">ACh</term><def><p textid="80">acetylcholine</p></def></def-item><def-item><term id="G7">AChE</term><def><p textid="81">acetylcholinesterase</p></def></def-item><def-item><term id="G8">AChE-S</term><def><p textid="82">synaptic AChE</p></def></def-item><def-item><term id="G9">ATCh</term><def><p textid="83">acetylthiocholine</p></def></def-item><def-item><term id="G10">AD</term><def><p textid="84">Alzheimer disease</p></def></def-item><def-item><term id="G11">A&#946;</term><def><p textid="85">&#946;-amyloid</p></def></def-item><def-item><term id="G12">polyP</term><def><p textid="86">poly-<sc>l</sc>-proline</p></def></def-item><def-item><term id="G13">bis-ANS</term><def><p textid="87">4,4&#8242;-dianilino-1,1&#8242;-binaphthyl-5,5&#8242;-sulfonate</p></def></def-item><def-item><term id="G14">TTR</term><def><p textid="88">Transthyretin</p></def></def-item><def-item><term id="G15">LDH</term><def><p textid="89">lactate dehydrogenase</p></def></def-item><def-item><term id="G16">TEM</term><def><p textid="90">transmission electron microscopy</p></def></def-item><def-item><term id="G17">ThT</term><def><p textid="91">thioflavin T</p></def></def-item><def-item><term id="G18">Tricine</term><def><p textid="92"><italic>N</italic>-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine</p></def></def-item><def-item><term id="G19">DMSO</term><def><p textid="93">dimethyl sulfoxide.</p></def></def-item></def-list>
The abbreviations used are: BChEbutyrylcholinesteraseBChE-KKalow variant of BChEBChE-Uusual BChErBChE-Urecombinant rBChE-UBSPBChE-derived synthetic peptideAChacetylcholineAChEacetylcholinesteraseAChE-Ssynaptic AChEATChacetylthiocholineADAlzheimer diseaseAbetabeta-amyloidpolyPpoly-l-prolinebis-ANS4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonateTTRTransthyretinLDHlactate dehydrogenaseTEMtransmission electron microscopyThTthioflavin TTricineN-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycineDMSOdimethyl sulfoxide.
###end p 74
###begin p 75
butyrylcholinesterase
###end p 75
###begin p 76
Kalow variant of BChE
###end p 76
###begin p 77
usual BChE
###end p 77
###begin p 78
recombinant rBChE-U
###end p 78
###begin p 79
BChE-derived synthetic peptide
###end p 79
###begin p 80
acetylcholine
###end p 80
###begin p 81
acetylcholinesterase
###end p 81
###begin p 82
synaptic AChE
###end p 82
###begin p 83
acetylthiocholine
###end p 83
###begin p 84
Alzheimer disease
###end p 84
###begin p 85
beta-amyloid
###end p 85
###begin p 86
###xml 5 6 5 6 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
poly-l-proline
###end p 86
###begin p 87
4,4'-dianilino-1,1'-binaphthyl-5,5'-sulfonate
###end p 87
###begin p 88
Transthyretin
###end p 88
###begin p 89
lactate dehydrogenase
###end p 89
###begin p 90
transmission electron microscopy
###end p 90
###begin p 91
thioflavin T
###end p 91
###begin p 92
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine
###end p 92
###begin p 93
dimethyl sulfoxide.
###end p 93
###begin title 94
Acknowledgments
###end title 94
###begin p 95
We are grateful to Dr. Tsafrir Bravman and Monica Dines (Bio-Rad, Haifa, Israel) for collaborative efforts.
###end p 95
###begin title 96
REFERENCES
###end title 96

